Literature DB >> 24368059

Equine epidermis: a source of epithelial-like stem/progenitor cells with in vitro and in vivo regenerative capacities.

Sarah Y Broeckx1, Sofie Maes, Tiziana Martinello, Désirée Aerts, Koen Chiers, Tom Mariën, Marco Patruno, Alfredo Franco-Obregón, Jan H Spaas.   

Abstract

Besides the presence of somatic stem cells in hair follicles and dermis, the epidermis also contains a subpopulation of stem cells, reflecting its high regenerative capacity. However, only limited information concerning epidermis-derived epithelial-like stem/progenitor cells (EpSCs) is available to date. Nonetheless, this stem cell type could prove itself useful in skin reconstitution after injury. After harvesting from equine epidermis, the purified cells were characterized as EpSCs by means of positive expression for CD29, CD44, CD49f, CD90, Casein Kinase 2β, p63, and Ki67, low expression for cytokeratin (CK)14 and negative expression for CD105, CK18, Wide CK, and Pan CK. Furthermore, their self-renewal capacity was assessed in adhesion as well as in suspension. Moreover, the isolated cells were differentiated toward keratinocytes and adipocytes. To assess the regenerative capacities of EpSCs, six full-thickness skin wounds were made: three were treated with EpSCs and platelet-rich-plasma (EpSC/PRP-treated), while the remaining three were administered carrier fluid alone (PRP-treated). The dermis of EpSC/PRP-treated wounds was significantly thinner and exhibited more restricted granulation tissue than did the PRP-treated wounds. The EpSC/PRP-treated wounds also exhibited increases in EpSCs, vascularization, elastin content, and follicle-like structures. In addition, combining EpSCs with a PRP treatment enhanced tissue repair after clinical application.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24368059     DOI: 10.1089/scd.2013.0203

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  6 in total

1.  Mesenchymal Stem Cell Therapy Alleviates Interstitial Cystitis by Activating Wnt Signaling Pathway.

Authors:  Miho Song; Jisun Lim; Hwan Yeul Yu; Junsoo Park; Ji-Youn Chun; Jaeho Jeong; Jinbeom Heo; Hyunsook Kang; YongHwan Kim; Yong Mee Cho; Seong Who Kim; Wonil Oh; Soo Jin Choi; Sung-Wuk Jang; Sanghyeok Park; Dong-Myung Shin; Myung-Soo Choo
Journal:  Stem Cells Dev       Date:  2015-04-09       Impact factor: 3.272

2.  Expression and localization of epithelial stem cell and differentiation markers in equine skin, eye and hoof.

Authors:  Renata L Linardi; Susan O Megee; Sarah R Mainardi; Makoto Senoo; Hannah L Galantino-Homer
Journal:  Vet Dermatol       Date:  2015-05-12       Impact factor: 1.589

3.  Allogeneic Stem Cells Alter Gene Expression and Improve Healing of Distal Limb Wounds in Horses.

Authors:  Jamie A Textor; Kaitlin C Clark; Naomi J Walker; Fabio A Aristizobal; Amir Kol; Sarah S LeJeune; Andrea Bledsoe; Arik Davidyan; Sarah N Gray; Laurie K Bohannon-Worsley; Kevin D Woolard; Dori L Borjesson
Journal:  Stem Cells Transl Med       Date:  2017-10-24       Impact factor: 6.940

4.  Knockdown of Tcf3 enhances the wound healing effect of bone marrow mesenchymal stem cells in rats.

Authors:  Bin He; Jia Chen; Liang Liu; Hao Wang; Shaohua Wang; Ping Li; Jianda Zhou
Journal:  Biosci Rep       Date:  2019-08-28       Impact factor: 3.840

Review 5.  Biobanking Organoids or Ground-State Stem Cells?

Authors:  Wa Xian; Marcin Duleba; Yusuke Yamamoto; Matthew Vincent; Frank McKeon
Journal:  J Clin Med       Date:  2018-12-16       Impact factor: 4.241

6.  Cellular and Humoral Immunogenicity Investigation of Single and Repeated Allogeneic Tenogenic Primed Mesenchymal Stem Cell Treatments in Horses Suffering From Tendon Injuries.

Authors:  Eva Depuydt; Sarah Y Broeckx; Koen Chiers; Marco Patruno; Laura Da Dalt; Luc Duchateau; Jimmy Saunders; Frederik Pille; Ann Martens; Lore Van Hecke; Jan H Spaas
Journal:  Front Vet Sci       Date:  2022-02-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.